LaFayette, NY – The 2018 Undoing Aging Conference, co-hosted by SENS Research Foundation and Michael Greve’s Forever Healthy Foundation, is a scientific forum focused on the cellular and molecular repair of age-related damage. It provides a platform for leading researchers from around the world to share their work in stem cells, senescent cells, immunotherapies, biomarkers, […]
Read the original article here LaFayette, NY – Each year Syracuse’s economic development counsel and chamber of commerce, CenterState CEO, recognizes Central New York businesses for their outstanding achievements during the past year. Ichor Therapeutics, Inc. has been selected as a finalist for 2018. “We feel very privileged for being selected as a finalist,” remarked […]
Darren Carpizo MD, PhD Brings His Knowledge and Expertise to Antoxerene Inc. Syracuse, NY, January 29th, 2017 – Antoxerene Inc, an affiliate of Ichor Therapeutics located in LaFayette, NY recently announced the addition of Darren Carpizo MD, PhD to the advisory board of Antoxerene Inc. Carpizo is a world expert on p53, and his knowledge […]
Link to original article By Stan Linhorst StanLinhorst@gmail.com, syracuse.com Kelsey Moody was a medical student at Upstate Medical University when he landed a $540,000 research grant and set up his own pharmaceutical research company. “After we had cleared our first million dollars in funding for the company, I had to choose: Did I want to finish my medical […]
Click for original article Aaron Wolfe expects to finish up his Ph.D. in physics this semester. He has been working on his doctorate since 2011 and should have been done by now, he says, but a few things have gotten in the way—like helping to run a company, Ichor Therapeutics, of which he is chief […]
Please click here for video. LAFAYETTE, N.Y. (WSYR-TV) – One Central New York start-up is looking to start human trials on their solution to macular degeneration– a disease that’s a leading cause of vision loss for over 10 million Americans. Ichor Therapeutics, based in LaFayette, is looking to make a name for itself. “There’s no […]
Ichor builds new partnerships and lands $600k investment for its Age-related Macular Degeneration (AMD) research initiative, which has shown positive early results. Age-related Macular Degeneration (AMD) is a presently incurable eye condition leading to partial loss of vision and affects as many as 15 million Americans and millions more globally. AMD has a significant impact […]
In March we signed on a new investor, Roger Bagg (you may have seen our press release over at MedTech, or the Town of Lafayette Newsletter – we’re glad everyone else was as excited as we were!). Roger is an ideal investor for Ichor. He has experience investing in other Biotech firms both in the US and the UK, […]
FOR IMMEDIATE RELEASE LaFayette, New York, March 2nd, 2016 Ichor Therapeutics, a local biotechnology company focusing on therapeutic interventions for age-related disease, receives $1.35 million in new funding — including $1 million from European investors — and begins a 4-fold expansion of research capabilities in LaFayette, NY to engage in FDA compliant pre-clinical research. Ichor was […]